Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-25

Clinical Trial Update: An Exploratory Analysis of Immune and Inflammatory Response Associated With Clozapine [Phase 4]

View source ↗

Summary

This Phase 4 exploratory trial investigated immune and inflammatory responses related to clozapine in treatment-resistant schizophrenia, but the study was termi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clozapine (Clozapine)

Snippet

Sponsor: Ohio State University | Conditions: Treatment-resistant Schizophrenia | Phase 4 | Status: TERMINATED